What is Pfizer's SG&A?

Pfizer (PFE) reported SG&A of $2.96B in Q1 2026.

How has Pfizer's SG&A changed year-over-year?

Pfizer's SG&A decreased by 2.3% year-over-year, from $3.03B to $2.96B.

What is the long-term trend for Pfizer's SG&A?

Over 4 years (2021 to 2025), Pfizer's SG&A has grown at a 2.1% compound annual growth rate (CAGR), from $12.7B to $13.79B.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

Pfizer PFE SG&A

SG&A at other companies

Bristol-Myers SquibbBMY

$1.62B+2.1%

Eli LillyLLY

$2.93B+18.9%

Johnson & JohnsonJNJ

$6.03B+18.0%

Merck & Co.MRK

$2.7B+5.8%

AmgenAMGN

$1.6B-5.0%

Ionis PharmaceuticalsIONS

$150.36M+97.2%

Segments

By segment

See full

Biopharma$2.13B-2.5%

Other financials

Income statement

See full

Revenue$14.5B+5.4%

Gross profit$10.9B+0.3%

Net income$2.7B-9.4%

EPS (diluted)$0.47-9.6%

Balance sheet

See full

Cash & equivalents$1.8B+18.8%

Total debt$64.4B+4.9%

Total equity$90.1B-0.3%

Total assets$207.62B-0.2%

Cash flow

See full

Operating cash flow$2.6B+12.0%

CapEx$436.0M-22.7%

Free cash flow$2.2B+23.0%

Valuation

See full

Market cap$134.91B-1.0%

Enterprise value$197.57B+0.7%

P/E11.1×—

P/S2.1×-0.1×

Profitability

See full

Gross margin73.5%+1.2pp

Net margin15.7%—

FCF margin18%+8.8pp

Returns & leverage

See full

Return on equity10.6%—

Debt / equity0.7×0.0×

Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pfizer's SG&A?: Pfizer (PFE) reported SG&A of $2.96B in Q1 2026.
How has Pfizer's SG&A changed year-over-year?: Pfizer's SG&A decreased by 2.3% year-over-year, from $3.03B to $2.96B.
What is the long-term trend for Pfizer's SG&A?: Over 4 years (2021 to 2025), Pfizer's SG&A has grown at a 2.1% compound annual growth rate (CAGR), from $12.7B to $13.79B.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.